HOME Top Market Reports Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

Bioabsorbable Stent/Bioresorbable Scaffold Market by Material (Polymer/Metal), Absorption Rate (Slow, Fast), Application (Coronary Artery Disease/CAD, Peripheral/PAD) & End User (Hospital, Cardiovascular Center) - Global Forecasts to 2022

By: marketsandmarkets.com
Publishing Date: August 2017
Report Code: MD 4383

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022.

The objectives of this study are as follows:

  • To define, describe, and estimate the bioresorbable stents market by material, absorption rate, application, and end user
  • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast size of the market segments with respect to four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW)2
  • To profile key participants and comprehensively analyze their market shares and core competencies3
  • To track and analyze competitive developments such as joint ventures, mergers and acquisitions; product developments, expansions; and research and development activities in the bioresorbable stents market

Research Methodology

The study estimates the global bioresorbable stents market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information of the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the global bioresorbable stents market. Primary sources from the demand include hospital purchase managers, surgeons, and physicians. For market estimation process both top-down and bottom-up approaches were used to estimate and validate the market size of the bioresorbable stents market as well as to estimate the market size of various other dependent submarkets. All possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. This data is consolidated and added to detailed inputs and analysis from MarketsandMarkets and presented in this report.

Bioabsorbable Stents Market

To know about the assumptions considered for the study, download the pdf brochure

The global bioresorbable stents market is niche with the presence of a limited number of players. Prominent players in the bioresorbable stents market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).

Target Audience for this Report:

  • Bioabsorbable stent manufacturing companies
  • Pharmaceutical manufacturing companies
  • Healthcare institutions (hospitals and clinics)
  • Stent distributors and suppliers
  • Research institutes
  • Venture capitalists
  • Health insurance payers
  • Market research and consulting firms

Scope of the Report

This report categorizes the global bioresorbable stents market into following segments and subsegments.

By Material

  • Bioresorbable polymer based stents     
  • Bioresorbable metallic stents    

By Absorption Rate

  • Slow- absorption stents
  • Fast- absorption stents

By Applications  

  • Coronary Artery Diseases
  • Peripheral Artery Diseases

By End User

  • Hospitals
  • Cardiac Centers

By Region

  • North America
  • Europe
  • Asia
  • RoW

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.

The following customization options are available for this report.

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Approach
    2.2 Secondary Data
    2.3 Primary Data
    2.4 Key Industry Insights
    2.5 Market Size Estimation
    2.6 Market Breakdown and Data Triangulation
    2.7 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 29)
    4.1 Bioresorbable Stents Market Overview
    4.2 Bioresorbable Stents Market, By End User
    4.3 Bioresorbable Stents Market, By Application
    4.4 Bioresorbable Stents Market, By Material
    4.5 Bioresorbable Stents Market: Geographic Snapshot

5 Market Overview (Page No. - 32)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rapidly Growing Geriatric Population and Increased Risk of CAD and PAD in the Elderly
                    5.2.1.2 Strong Product Pipeline
           5.2.2 Restraints
                    5.2.2.1 Presence of Substitutes
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets to Offer High-Growth Opportunities for Market PartiCIPAnts
           5.2.4 Challenges
                    5.2.4.1 Product Withdrawals and Failures
                    5.2.4.2 High Risk of Complications

6 Regulatory Scenario (Page No. - 38)
    6.1 Introduction
    6.2 FDA and Ce Approvals
    6.3 PMA Approvals and Government Certificates

7 Bioresorbable Stents Market, By Material (Page No. - 40)
    7.1 Introduction
    7.2 Bioresorbable Polymer-Based Stents
    7.3 Bioresorbable Metallic Stents

8 Bioresorbable Stents Market, By Absorption Rate (Page No. - 46)
    8.1 Introduction
    8.2 Slow-Absorption Stents
    8.3 Fast-Absorption Stents

9 Bioresorbable Stents Market, By Application (Page No. - 51)
    9.1 Introduction
    9.2 Coronary Artery Disease
    9.3 Peripheral Artery Disease

10 Bioresorbable Stents Market, By End User (Page No. - 57)
     10.1 Introduction
     10.2 Hospitals
     10.3 Cardiac Centers

11 Bioresorbable Stents Market, By Region (Page No. - 63)
     11.1 Introduction
     11.2 Europe
             11.2.1 Germany
             11.2.2 France
             11.2.3 U.K.
             11.2.4 Rest of Europe (RoE)
     11.3 Asia
     11.4 North America
             11.4.1 U.S.
             11.4.2 Canada
     11.5 Rest of the World

12 Competitive Landscape (Page No. - 89)
     12.1 Introduction
     12.2 Market Ranking Analysis
     12.3 Competitive Leadership Mapping
             12.3.1 Visionary Leaders
             12.3.2 Innovators
             12.3.3 Emerging Companies
             12.3.4 Dynamic Differentiators
     12.4 Competitive Benchmarking
             12.4.1 Strength of the Product Portfolio
             12.4.2 Business Strategy Excellence

Abbott, REVA Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING  Co., Ltd., BIOTRONIK, Amaranth Medical, Inc., Arterial Remodeling Technologies, Meril Life Sciences Pvt. Ltd., Arterius Limited, LEPU MEDICAL TECHNOLOGY CO., LTD., Boston Scientific Corporation, HangZhou HuaAn  Biotechnology Co.,Ltd, S3V Vascular Technologies, QualiMed, SMT, TEPHA INC, Manli Cardiology Ltd., ORBUSNEICH, 480 Biomedical, Zorion Medical Inc, Lifetech Scientific (Shenzhen) Co., Ltd

13 Company Profiles (Page No. - 94)
(Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships)*
     13.1 Abbott
     13.2 REVA Medical, Inc.
     13.3 Elixir Medical Corporation
     13.4 KYOTO MEDICAL PLANNING  Co., Ltd.
     13.5 BIOTRONIK
     13.6 Amaranth Medical, Inc.
     13.7 Arterial Remodeling Technologies
     13.8 Meril Life Sciences Pvt. Ltd.
     13.9 Arterius Limited
     13.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
     13.11 Boston Scientific Corporation
     13.12 480 Biomedical
     13.13 S3V Vascular Technologies Private Limited
     13.14 Qualimed (Part of Q3 Medical Group)
     13.15 ORBUSNEICH

*Details on Business Overview, Strength of Service Portfolio, Business Strategy Excellence, and Key Relationships Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 128)
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (73 Tables)

Table 1 Pipeline Products in the Bioresorbable Stents Market
Table 2 List of the Approved Products
Table 3 Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 4 Bioresorbable Polymer-Based Stents Market, By Region, 2015–2022 (USD Million)
Table 5 North America: Bioresorbable Polymer-Based Stents Market, By Country, 2015–2022 (USD Million)
Table 6 Europe: Bioresorbable Polymer-Based Stents Market, By Country, 2015–2022 (USD Million)
Table 7 Bioresorbable Metallic Stents Market, By Region, 2017–2022 (USD Million)
Table 8 Europe: Bioresorbable Metallic Stents Market, By Country, 2017–2022 (USD Million)
Table 9 Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 10 Slow-Absorption Stents Market, By Region, 2015–2022 (USD Million)
Table 11 Europe: Slow-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 12 North America: Slow-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 13 Fast-Absorption Stents Market, By Region, 2015–2022 (USD Million)
Table 14 Europe: Fast-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 15 North America: Fast-Absorption Stents Market, By Country, 2015–2022 (USD Million)
Table 16 Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 17 Bioresorbable Stents Market for Coronary Artery Disease, By Region, 2015–2022 (USD Million)
Table 18 North America: Bioresorbable Stents Market for Coronary Artery Disease, By Country, 2015–2022 (USD Million)
Table 19 Europe: Bioresorbable Stents Market for Coronary Artery Disease, By Country, 2015–2022 (USD Million)
Table 20 Bioresorbable Stents Market for Peripheral Artery Disease, By Region, 2015–2022 (USD Million)
Table 21 Europe: Bioresorbable Stents Market for Peripheral Artery Disease, By Country, 2015–2022 (USD Million)
Table 22 Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 23 Bioresorbable Stents Market for Hospitals, By Region, 2015–2022 (USD Million)
Table 24 North America: Bioresorbable Stents Market for Hospitals, By Country, 2015–2022 (USD Million)
Table 25 Europe: Bioresorbable Stents Market for Hospitals, By Country, 2015–2022 (USD Million)
Table 26 Bioresorbable Stents Market for Cardiac Centers, By Region, 2015–2022 (USD Million)
Table 27 North America: Bioresorbable Stents Market for Cardiac Centers, By Country, 2015–2022 (USD Million)
Table 28 Europe: Bioresorbable Stents Market for Cardiac Centers, By Country, 2015–2022 (USD Million)
Table 29 Bioresorbable Stents Market, By Region, 2015–2022 (USD Million)
Table 30 Bioresorbable Stents Market, By Region, 2015–2022 (Units)
Table 31 Europe: Bioresorbable Stents Market, By Country, 2015–2022 (USD Million)
Table 32 Europe: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 33 Europe: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 34 Europe: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 35 Europe: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 36 Germany: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 37 Germany: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 38 Germany: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 39 Germany: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 40 France: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 41 France: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 42 France: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 43 France: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 44 U.K.: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 45 U.K.: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 46 U.K.: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 47 U.K.: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 48 RoE: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 49 RoE: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 50 RoE: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 51 RoE: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 52 Asia: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 53 Asia: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 54 Asia: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 55 Asia: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 56 North America: Bioresorbable Stents Market, By Country, 2015–2022 (USD Million)
Table 57 North America: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 58 North America: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 59 North America: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 60 North America: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 61 U.S.: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 62 U.S.: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 63 U.S.: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 64 U.S.: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 65 Canada: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 66 Canada: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 67 Canada: Bioresorbable Stents Market, By Type, 2015–2022 (USD Million)
Table 68 Canada: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 69 RoW: Bioresorbable Stents Market, By Material, 2015–2022 (USD Million)
Table 70 RoW: Bioresorbable Stents Market, By Absorption Rate, 2015–2022 (USD Million)
Table 71 RoW: Bioresorbable Stents Market, By Application, 2015–2022 (USD Million)
Table 72 RoW: Bioresorbable Stents Market, By End User, 2015–2022 (USD Million)
Table 73 Bioresorbable Stents Market Ranking Analysis, By Key Player, 2016
 
 
List of Figures (33 Figures)
 
Figure 1 Bioresorbable Stents Market
Figure 2 Research Design
Figure 3 Key Data From Secondary Sources
Figure 4 Key Data From Primary Sources
Figure 5 Market Size Estimation: Bottom -Up Approach
Figure 6 Market Size Estimation: Top-Down Approach
Figure 7 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 8 Data Triangulation Methodology
Figure 9 Bioresorbable Polymer-Based Stents to Dominate the Market During the Forecast Period
Figure 10 Bioresorbable Stents Market, By Absorption Rate (2017 vs 2022)
Figure 11 Coronary Artery Disease to Register Highest Growth in the Bioresorbable Stents Application Market (2017-2022)
Figure 12 Hospitals to Offer Significant Growth Opportunities During the Forecast Period
Figure 13 North America is Expected to Witness the Highest Growth During the Forecast Period
Figure 14 Rising Geriatric Population and Increased Risk of CAD and PAD to Drive Market Growth During the Forecast Period
Figure 15 Hospitals Accounted for the Largest Market Share in 2017
Figure 16 Coronary Artery Diseases to Witness Highest Growth During the Forecast Period
Figure 17 Bioresorbable Polymer-Based Stents to Witness the Highest Growth During the Forecast Period
Figure 18 North America to Witness the Highest Growth in the Bioresorbable Stents Market During the Forecast Period
Figure 19 Bioresorbable Stents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Prevalence of CAD, By Age and Gender (2009–2012)
Figure 21 Bioabsorbable Stents Market, By Material (2017 vs 2022)
Figure 22 Slow Absorption Stents to Dominate the Bioresorbable Stents Market in 2017
Figure 23 Coronary Artery Disease to Dominate the Bioresorbable Stents Application Market in 2017
Figure 24 Hospitals to Register Highest Growth in the Bioresorbable Stents End-User Market in 2017
Figure 25 Europe to Dominate the Bioresorbable Stents Market in 2017
Figure 26 Europe: Bioresorbable Stents Market Snapshot
Figure 27 Asia: Bioresorbable Stents Market Snapshot
Figure 28 North America: Bioresorbable Stents Market Snapshot
Figure 29 RoW Bioresorbable Stents Market Snapshot (2017)
Figure 30 Competitive Leadership Mapping
Figure 31 Abbott: Company Snapshot (2016)
Figure 32 REVA Medical, Inc.: Company Snapshot (2016)
Figure 33 Boston Scientific Corporation: Company Snapshot (2016)

The global bioresorbable stents market is expected to reach USD 417.2 Million by 2022 from USD 223.6 Million in 2016, at a CAGR of 11.5% during the forecast period 2017-2022. Market growth of bioresorbable stents is attributed to the growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies. However, factors such as the increasing product withdrawals due to severe complications of these stents may hamper market growth.

This report segments the global bioresorbable stents market into material, absorption rate, applications, end users, and region. On the basis of materials, the global bioresorbable stents market is segmented into bioresorbable polymer-based stents and bioresorbable metallic stents. The bioresorbable polymer-based segment is expected to dominate the market in 2017. The preference for bioresorbable polymer-based stents is rising in the market as companies are increasingly focusing on developing polymeric stents and approvals for polymer-based stents across various regions are driving the market.

Based on end users, the market is segmented into hospitals and cardiac centers. The hospitals segment is expected to dominate the market and grow at the highest CAGR of during the forecast period. The high growth in this segment is attributed to increasing need of surgeries, growing risk of CAD and PAD, and improving reimbursement scenario for the hospitals.

By absorption rate, the global bioresorbable stents market is segmented into slow-absorption stents and fast-absorption stents. In 2017, the slow-absorption stents segment is expected to account for the largest share of the market. The large share of this segment can be attributed to the advantages it offers such as the longer duration of drug release within the artery provided by these stents and the reduced need for stent re-implantation.

Bioabsorbable Stents Market

In 2017, Europe is expected to dominate the global bioresorbable stents market. Factors such as increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents in the region are expected to drive the growth of this regional segment.

The global bioresorbable stents market is a niche market with the presence of several emerging players. Prominent players in the bioresorbable stents market include Abbott Laboratories (U.S.), BIOTRONIK SE & Co. KG (Germany), REVA Medical, Inc. (U.S.), Elixir Medical Corporation (U.S.), and Kyoto Medical Planning Co., Ltd. (Japan).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo